ArticleThe Journal of pathology2018

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.

Elena Martínez-Terroba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.